Chemours (CC) Capital Expenditures (2014 - 2026)

Chemours' Capital Expenditures history runs 13 years deep, the most recent figure standing at $27.0 million for Q1 2026.

• In Q1 2026, Capital Expenditures rose 3.85% year-over-year to $27.0 million; the TTM figure through Mar 2026 stood at $214.0 million (up 1683.33% YoY), while the FY2025 annual figure was $213.0 million, up 142.05% from the prior year.
• Capital Expenditures was $27.0 million for Q1 2026 at Chemours, down from $45.0 million in the prior quarter.
• In the past five years, Capital Expenditures ranged from a high of $265.0 million in Q4 2022 to a low of -$163.0 million in Q4 2024.
• Historically, Capital Expenditures has averaged $44.8 million across 5 years, with a median of $41.0 million in 2022.
• Biggest YoY gain for Capital Expenditures was 383.56% in 2024; the steepest drop was 2816.67% in 2024.
• A 5-year view of Capital Expenditures shows it stood at $265.0 million in 2022, then slumped by 97.74% to $6.0 million in 2023, then tumbled by 2816.67% to -$163.0 million in 2024, then surged by 127.61% to $45.0 million in 2025, then slumped by 40.0% to $27.0 million in 2026.
• The last three Capital Expenditures figures came in at $27.0 million (Q1 2026), $45.0 million (Q4 2025), and $142.0 million (Q3 2025), per Business Quant data.